sctovc
UNITED STATES SECURITIES AND
EXCHANGE COMMISSION
Washington, DC
20549
SCHEDULE TO
(Rule 14d-100)
TENDER OFFER STATEMENT UNDER
SECTION 14(D)(1) OR 13(E)(1) OF
THE SECURITIES EXCHANGE ACT OF 1934
I-TRAX, INC.
(Name Of Subject Company
(Issuer))
WALGREEN CO.
PUTTER ACQUISITION SUB,
INC.
(Names of Filing Persons
(Offerors))
Common Stock, par value $0.001 per share
(CUSIP Number 45069D203)
Series A Convertible Preferred Stock, par value $0.001 per
share
(CUSIP Number not applicable for Preferred Stock)
Dana Ione Green, Esq.
Walgreen Co. Law Department
200 Wilmot Road
Deerfield, IL 60015
Telephone:
(847) 914-2500
(Name, address and telephone
number of person authorized
to receive notices and communications on behalf of filing
persons)
with a copy to:
Keith S. Crow, P.C.
Robert M. Hayward
Gregory C. Vogelsperger
Kirkland & Ellis LLP
200 East Randolph Drive
Chicago, IL 60601
Telephone:
(312) 861-2000
CALCULATION
OF FILING FEE
|
|
|
Transaction Valuation*
|
|
Amount of Filing Fee*
|
|
Not Applicable
|
|
Not Applicable
|
|
|
|
* |
|
Pursuant to General Instruction D to Schedule TO, no
filing fee is required because communications made before the
commencement of a tender offer. |
|
|
o |
Check the box if any part of the fee is offset as provided by
Rule 0-11(a)(2)
and identify the filing with which the offsetting fee was
previously paid. Identify the previous filing by registration
statement number or the Form or Schedule and the date of its
filing.
|
|
|
|
Amount Previously Paid: N/A
Form or Registration No.: N/A
|
|
Filing Party: N/A
Date Filed: N/A
|
|
|
þ |
Check the box if the filing relates solely to preliminary
communications made before the commencement of a tender offer.
|
Check the appropriate boxes below to designate any transactions
to which the statement relates:
þ third-party
tender offer subject to
Rule 14d-1.
o issuer
tender offer subject to
Rule 13e-4.
o going-private
transaction subject to
Rule 13e-3.
o amendment
to Schedule 13D under
Rule 13d-2.
Check the following box if the filing is a final amendment
reporting the results of the tender
offer: o
This Tender Offer Statement on Schedule TO (this
Statement) relates to a planned tender
offer by Putter Acquisition Sub, Inc., a Delaware corporation
(Offeror) and a wholly owned
subsidiary of Walgreen Co., an Illinois corporation
(Walgreens), for all of the issued and
outstanding shares of common stock, par value $0.001 per share
(the Common Shares) and all of the issued and
outstanding shares of Series A Convertible Preferred Stock,
par value $0.001 per share (the Preferred
Shares and together with the Common Shares the
Shares) of I-trax, Inc., a Delaware
corporation (I-trax) to be commenced
pursuant to an Agreement and Plan of Merger, dated as of
March 14, 2008, by and among Offeror, Walgreens and I-trax.
Additional
Information and Where to Find It
In connection with the tender offer, Walgreens intends to
file a tender offer statement on Schedule TO and related
materials with the Securities and Exchange Commission (the
SEC), and I-trax will file a
solicitation/recommendation statement on
Schedule 14D-9
with the SEC. Investors and security holders are strongly
advised to read these documents when they become available
because they will contain important information about the tender
offer and the proposed merger. Free copies of materials, which
will be filed by Walgreens and I-trax, will be available at the
SECs Web site at www.sec.gov, or with respect to Walgreens
materials, at www.walgreens.com, and also will be available,
without charge, by directing requests to Walgreens, and with
respect to I-trax materials, at www.i-trax.com, and will also be
available, without charge, by directing requests to I-trax.
Important
information
This document is for informational purposes only and is not an
offer to buy or the solicitation of an offer to sell any
securities. The solicitation and the offer to buy shares of
I-traxs common stock and Series A Convertible
Preferred Stock will only be made pursuant to an offer to
purchase and related materials that Walgreens intends to file
with the Securities and Exchange Commission. I-trax will file a
solicitation/recommendation statement with respect to the offer.
Once filed, I-trax stockholders should read these materials
carefully prior to making any decisions with respect to the
offer because they contain important information, including the
terms and conditions of the offer. Once filed, I-trax
stockholders will be able to obtain the offer to purchase, the
solicitation/recommendation statement and related materials with
respect to the offer free of charge at the SECs Web site
at www.sec.gov, from the information agent named in the tender
offer materials, from I-trax or from Walgreens.
|
|
|
|
|
Exhibit
|
|
|
No.
|
|
Description
|
|
|
99
|
.1
|
|
Press Release, dated March 17, 2008, by Walgreen Co.
|
|
99
|
.2
|
|
Transcript of March 17, 2008 Walgreen Conference Call
|
SIGNATURES
After due inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is
true, complete and correct.
|
|
|
Dated: March 18, 2008
|
|
WALGREEN CO.
|
|
|
|
|
By:
|
/s/ William
M. Rudolphsen
|
Name: William M. Rudolphsen
|
|
|
|
Title:
|
Senior Vice President
|
PUTTER ACQUISITION SUB, INC.
|
|
|
|
By:
|
/s/ William
M. Rudolphsen
|
Name: William M. Rudolphsen